[Congressional Record Volume 167, Number 40 (Wednesday, March 3, 2021)]
[Senate]
[Pages S1021-S1022]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
FOOD ALLERGY SAFETY, TREATMENT, EDUCATION, AND RESEARCH ACT OF 2021
Mr. DURBIN. Madam President, I ask unanimous consent that the Senate
proceed to the immediate consideration of S. 578, which was introduced
earlier today.
The PRESIDING OFFICER. The clerk will report the bill by title.
The legislative clerk read as follows:
A bill (S. 578) to improve the health and safety of
Americans living with food allergies and related disorders,
including potentially life-threatening anaphylaxis, food
protein-induced enterocolitis syndrome, and eosinophilic
gastrointestinal diseases, and for other purposes.
There being no objection, the Senate proceeded to consider the bill.
Mr. DURBIN. I further ask that the bill be read a third time and
passed and the motion to reconsider be considered made and laid upon
the table with no intervening action or debate.
The PRESIDING OFFICER. Without objection, it is so ordered.
The bill (S. 578) was ordered to be engrossed for a third reading,
was read the third time, and passed, as follows
S. 578
Be it enacted by the Senate and House of Representatives of
the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Food Allergy Safety,
Treatment, Education, and Research Act of 2021'' or the
``FASTER Act of 2021''.
SEC. 2. FOOD ALLERGY SAFETY.
(a) In General.--Section 201(qq)(1) of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 321(qq)(1)) is amended by
striking ``and soybeans'' and inserting ``soybeans, and
sesame''.
(b) Effective Date.--The amendment made by subsection (a)
shall apply to any food that is introduced or delivered for
introduction into interstate commerce on or after January 1,
2023.
SEC. 3. REPORT TO CONGRESS.
(a) Report.--Not later than 18 months after the date of
enactment of this Act, the Secretary of Health and Human
Services (referred to in this section as the ``Secretary'')
shall submit to the Committee on Health, Education, Labor,
and Pensions of the Senate and the Committee on Energy and
Commerce of the House of Representatives a report that
includes--
(1) descriptions of ongoing Federal activities related to--
(A) the surveillance and collection of data on the
prevalence of food allergies and severity of allergic
reactions for specific food or food ingredients, including
the identification of any gaps in such activities;
(B) the development of effective food allergy diagnostics;
(C) the prevention of the onset of food allergies;
(D) the reduction of risks related to living with food
allergies; and
(E) the development of new therapeutics to prevent, treat,
cure, and manage food allergies; and
(2) specific recommendations and strategies to expand,
enhance, or improve activities described in paragraph (1),
including--
[[Page S1022]]
(A) strategies to improve the accuracy of food allergy
prevalence data by expanding and intensifying current
collection methods, including support for research that
includes the identification of biomarkers and tests to
validate survey data and the investigation of the use of
identified biomarkers and tests in national surveys;
(B) strategies to overcome gaps in surveillance and data
collection activities related to food allergies and specific
food allergens; and
(C) recommendations for the development and implementation
of a regulatory process and framework that would allow for
the timely, transparent, and evidence-based modification of
the definition of ``major food allergen'' included in section
201(qq) of the Federal Food, Drug and Cosmetic Act (21 U.S.C.
321(qq)), including with respect to--
(i) the scientific criteria for defining a food or food
ingredient as a ``major food allergen'' pursuant to such
process, including recommendations pertaining to evidence of
the prevalence and severity of allergic reactions to a food
or food ingredient that would be required in order to
establish that such food or food ingredient is an allergen of
public health concern appropriate for such process; and
(ii) opportunities for stakeholder engagement and comment,
as appropriate, in considering any such modification to such
definition.
(b) Publication.--The Secretary shall make the report under
subsection (a) available on the internet website of the
Department of Health and Human Services.
____________________